| Year |
Citation |
Score |
| 2023 |
Kübler D, Kobylecki C, McDonald KR, Anton-Rodriguez JM, Herholz K, Carter SF, Hinz R, Thompson JC, Al-Fatly B, Gerhard A. Structural and metabolic correlates of neuropsychological profiles in multiple system atrophy and Parkinson's disease. Parkinsonism & Related Disorders. 107: 105277. PMID 36621156 DOI: 10.1016/j.parkreldis.2022.105277 |
0.509 |
|
| 2022 |
Tomassen J, den Braber A, van der Lee SJ, Reus LM, Konijnenberg E, Carter SF, Yaqub M, van Berckel BNM, Collij LE, Boomsma DI, de Geus EJC, Scheltens P, Herholz K, Tijms BM, Visser PJ. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score. Bmc Neurology. 22: 484. PMID 36522743 DOI: 10.1186/s12883-022-02925-6 |
0.593 |
|
| 2022 |
Michalowska MM, Herholz K, Hinz R, Amadi C, McInnes L, Anton-Rodriguez JM, Karikari TK, Blennow K, Zetterberg H, Ashton NJ, Pendleton N, Carter SF. Evaluation of in vivo staging of amyloid deposition in cognitively unimpaired elderly aged 78-94. Molecular Psychiatry. PMID 35858992 DOI: 10.1038/s41380-022-01685-6 |
0.598 |
|
| 2021 |
Bellaver B, Ferrari-Souza JP, Uglione da Ros L, Carter SF, Rodriguez-Vieitez E, Nordberg A, Pellerin L, Rosa-Neto P, Leffa DT, Zimmer ER. Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis. Neurology. PMID 33952650 DOI: 10.1212/WNL.0000000000012109 |
0.505 |
|
| 2021 |
Mak E, Dounavi ME, Low A, Carter SF, McKiernan E, Williams GB, Jones PS, Carriere I, Muniz GT, Ritchie K, Ritchie C, Su L, O'Brien JT. PROXIMITY TO DEMENTIA ONSET AND MULTI-MODAL NEUROIMAGING CHANGES: THE PREVENT-DEMENTIA STUDY. Neuroimage. 117749. PMID 33454416 DOI: 10.1016/j.neuroimage.2021.117749 |
0.383 |
|
| 2020 |
Mak E, Nicastro N, Malpetti M, Savulich G, Surendranathan A, Holland N, Passamonti L, Jones PS, Carter SF, Su L, Hong YT, Fryer TD, Williams GB, Aigbirhio F, Rowe JB, et al. Imaging tau burden in dementia with Lewy bodies using [F]-AV1451 positron emission tomography. Neurobiology of Aging. 101: 172-180. PMID 33631469 DOI: 10.1016/j.neurobiolaging.2020.11.006 |
0.471 |
|
| 2020 |
Nicastro N, Holland N, Savulich G, Carter SF, Mak E, Hong YT, Milicevic Sephton S, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT. C-UCB-J synaptic PET and multimodal imaging in dementia with Lewy bodies. European Journal of Hybrid Imaging. 4: 25. PMID 33381679 DOI: 10.1186/s41824-020-00093-9 |
0.355 |
|
| 2020 |
Nicastro N, Malpetti M, Mak E, Williams GB, Bevan-Jones WR, Carter SF, Passamonti L, Fryer TD, Hong YT, Aigbirhio FI, Rowe JB, O'Brien JT. Gray matter changes related to microglial activation in Alzheimer's disease. Neurobiology of Aging. 94: 236-242. PMID 32663716 DOI: 10.1016/J.Neurobiolaging.2020.06.010 |
0.429 |
|
| 2019 |
Altomare D, Ferrari C, Caroli A, Galluzzi S, Prestia A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo ILH, Grimmer T, et al. Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset. Journal of Neurology. PMID 31267207 DOI: 10.1007/S00415-019-09441-7 |
0.575 |
|
| 2019 |
Carter SF, Herholz K, Rosa-Neto P, Pellerin L, Nordberg A, Zimmer ER. Astrocyte Biomarkers in Alzheimer's Disease. Trends in Molecular Medicine. PMID 30611668 DOI: 10.1016/J.Molmed.2018.11.006 |
0.679 |
|
| 2019 |
Asghar M, Hinz R, Herholz K, Carter SF. Dual-phase [18F]florbetapir in frontotemporal dementia. European Journal of Nuclear Medicine and Molecular Imaging. 46: 304-311. PMID 30569187 DOI: 10.1007/S00259-018-4238-2 |
0.612 |
|
| 2019 |
Carter SF, Chiotis K, Nordberg A, Rodriguez-Vieitez E. Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 46: 348-356. PMID 30515545 DOI: 10.1007/S00259-018-4217-7 |
0.749 |
|
| 2018 |
Legdeur N, Badissi M, Carter SF, de Crom S, van de Kreeke A, Vreeswijk R, Trappenburg MC, Oudega ML, Koek HL, van Campen JP, Keijsers CJPW, Amadi C, Hinz R, Gordon MF, Novak G, et al. Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study. Bmc Geriatrics. 18: 289. PMID 30477432 DOI: 10.1186/S12877-018-0984-Z |
0.603 |
|
| 2018 |
Konijnenberg E, Carter SF, Ten Kate M, den Braber A, Tomassen J, Amadi C, Wesselman L, Nguyen HT, van de Kreeke JA, Yaqub M, Demuru M, Mulder SD, Hillebrand A, Bouwman FH, Teunissen CE, et al. The EMIF-AD PreclinAD study: study design and baseline cohort overview. Alzheimer's Research & Therapy. 10: 75. PMID 30075734 DOI: 10.1186/S13195-018-0406-7 |
0.66 |
|
| 2018 |
Rodrigues YE, Peixoto GGS, Rocha ASd, Gehres SW, Fontana IC, Manica E, Souza DO, Carter SF, Zimmer ER, Lab Z. P3-400: A Novel Method For Defining Individual Metabolic Networks Derived From [18F]Fdg Pet Data Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1762 |
0.386 |
|
| 2016 |
Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Schöll M, Almkvist O, Wall A, Långström B, Nordberg A. Comparison of Early-Phase 11C-Deuterium-L-Deprenyl and 11C-PiB PET for Assessing Brain Perfusion in Alzheimer's Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26912447 DOI: 10.2967/Jnumed.115.168732 |
0.786 |
|
| 2016 |
Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Graff C, Wall A, Långström B, Nordberg A. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 26813969 DOI: 10.1093/Brain/Awv404 |
0.795 |
|
| 2016 |
Carter SF, Parkes L, Hinz R, Herholz K. P4-343: Cerebral Brain Perfusion in Cognitively Normal Advanced Elderly (79-93 Years) Measured with Arterial Spin Labelling and [18F]Flutemetamol PET: A Cross Modality Comparison Alzheimer's & Dementia. 12: P1166-P1166. DOI: 10.1016/J.Jalz.2016.07.087 |
0.576 |
|
| 2016 |
Legdeur N, Herholz K, Carter SF, Gordon MF, Novak GP, Li DJ, Scheltens P, Maier AB, Visser PJ. P2-165: Resilience to Clinical Dementia at Old Age: The European Medical Information Framework (EMIF) 90+ Study Alzheimer's & Dementia. 12: P678-P678. DOI: 10.1016/J.Jalz.2016.06.1332 |
0.506 |
|
| 2015 |
Schöll M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A. Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography. Scientific Reports. 5: 16404. PMID 26553227 DOI: 10.1038/Srep16404 |
0.755 |
|
| 2015 |
Zwan MD, Rinne JO, Hasselbalch SG, Nordberg A, Lleó A, Herukka SK, Soininen H, Law I, Bahl JM, Carter SF, Fortea J, Blesa R, Teunissen CE, Bouwman FH, van Berckel BN, et al. Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study. Neurology. PMID 26468410 DOI: 10.1212/Wnl.0000000000002081 |
0.618 |
|
| 2015 |
Farid K, Carter SF, Rodriguez-Vieitez E, Almkvist O, Andersen P, Wall A, Blennow K, Portelius E, Zetterberg H, Nordberg A. Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition. Journal of Alzheimer's Disease : Jad. 47: 661-7. PMID 26401701 DOI: 10.3233/Jad-141965 |
0.745 |
|
| 2015 |
Chiotis K, Carter SF, Farid K, Savitcheva I, Nordberg A. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1492-506. PMID 26130168 DOI: 10.1007/S00259-015-3115-5 |
0.762 |
|
| 2015 |
Leuzy A, Carter SF, Chiotis K, Almkvist O, Wall A, Nordberg A. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 45: 1077-88. PMID 25649653 DOI: 10.3233/Jad-142952 |
0.828 |
|
| 2015 |
Prestia A, Caroli A, Wade SK, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25646957 DOI: 10.1016/J.Jalz.2014.12.001 |
0.673 |
|
| 2015 |
Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen C, Wall AE, Carter SF, Schöll M, Choo IH, Grimmer T, Redolfi A, et al. Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression. Neurology. 84: 508-15. PMID 25568301 DOI: 10.1212/Wnl.0000000000001209 |
0.504 |
|
| 2015 |
Caroli A, Galluzzi S, Ferrari C, Prestia A, Flier WMvd, Ossenkoppele R, Berckel BNMv, Barkhof F, Teunissen CE, Wall A, Carter SF, Scholl M, Choo IH, Grimmer T, Redolfi A, et al. Alzheimer’s disease core biomarkers and prediction of dementia in MCI: The effect of age at onset Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.064 |
0.536 |
|
| 2015 |
Rodriguez-Vieitez E, Carter SF, Saint-Aubert L, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A. O1-02-03: Divergent pattern of changes in astrocytosis and fibrillar amyloid plaques as measured by PET in autosomal-dominant and sporadic Alzheimer's disease Alzheimer's & Dementia. 11: P127-P127. DOI: 10.1016/j.jalz.2015.07.035 |
0.615 |
|
| 2015 |
Rodriguez-Vieitez E, Carter SF, Saint-Aubert L, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A. IC-P-126: Divergent pattern of changes in astrocytosis and fibrillar amyloid plaques as measured by PET in autosomal-dominant and sporadic Alzheimer's disease Alzheimer's & Dementia. 11: P86-P86. DOI: 10.1016/J.Jalz.2015.06.148 |
0.8 |
|
| 2015 |
Chiotis K, Carter SF, Farid K, Savitcheva I, Nordberg A. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging European Journal of Nuclear Medicine and Molecular Imaging. 42: 1492-1506. DOI: 10.1007/s00259-015-3115-5 |
0.509 |
|
| 2014 |
Choo IL, Carter SF, Schöll ML, Nordberg A. Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients. European Journal of Nuclear Medicine and Molecular Imaging. 41: 2120-6. PMID 25077930 DOI: 10.1007/S00259-014-2859-7 |
0.652 |
|
| 2014 |
Carter SF, Embleton KV, Anton-Rodriguez JM, Burns A, Ralph MA, Herholz K. Regional neuronal network failure and cognition in late-onset sporadic Alzheimer disease. Ajnr. American Journal of Neuroradiology. 35: S18-30. PMID 24578281 DOI: 10.3174/Ajnr.A3895 |
0.576 |
|
| 2014 |
Chiotis K, Carter SF, Farid K, Nordberg A. P3-218: AGE IS A SIGNIFICANT FACTOR IN DETERMINING PATHOLOGICAL POSITIVITY MEASURED WITH [18F]FLORBETAPIR PET Alzheimer's & Dementia. 10: P710-P711. DOI: 10.1016/j.jalz.2014.05.1309 |
0.474 |
|
| 2014 |
Farid K, Almkvist O, Brueggen K, Carter SF, Wall A, Herholz K, Nordberg A. P3-215: HIGH PUTAMEN 11C-PIB RETENTION IN MCI IS ASSOCIATED WITH AN INCREASED RISK OF CONVERSION TO AD Alzheimer's & Dementia. 10: P709-P710. DOI: 10.1016/j.jalz.2014.05.1306 |
0.718 |
|
| 2014 |
Rodriguez-Vieitez E, Butina K, Carter SF, Nordberg A. P3-214: COMPARISON OF MEASUREMENTS OF CEREBRAL BLOOD FLOW BY EARLY FRAMES OF 11C-DEUTERIUM-L-DEPRENYL (11C-DED) AND 11C-PIB PET TRACERS AT DIFFERENT STAGES OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P709-P709. DOI: 10.1016/j.jalz.2014.05.1305 |
0.357 |
|
| 2014 |
Chiotis K, Carter SF, Farid K, Nordberg A. IC-P-025: AGE IS A SIGNIFICANT FACTOR IN DETERMINING PATHOLOGICAL POSITIVITY MEASURED WITH [18F]FLORBETAPIR PET Alzheimer's & Dementia. 10: P18-P18. DOI: 10.1016/J.Jalz.2014.05.029 |
0.714 |
|
| 2014 |
Farid K, Almkvist O, Brueggen K, Carter SF, Wall A, Herholz K, Nordberg A. IC-P-019: HIGH PUTAMEN 11C-PIB RETENTION IN MCI IS ASSOCIATED WITH AN INCREASED RISK OF CONVERSION TO AD Alzheimer's & Dementia. 10: P16-P16. DOI: 10.1016/J.Jalz.2014.05.023 |
0.721 |
|
| 2014 |
Caroli A, Frisoni G, Prestia A, Galluzzi S, Ferrari C, Flier WMVd, Ossenkoppele R, Berckel Bv, Barkhof F, Teunissen C, Wall A, Carter SF, Schöll M, Choo IH, Grimmer T, et al. Mild Cognitive Impairment With Suspected Non Ad Pathology (Snap): Prediction Of Progression To Dementia Alzheimers & Dementia. 10: 19-19. DOI: 10.1016/J.Jalz.2014.04.230 |
0.596 |
|
| 2014 |
Rodriguez-Vieitez E, Butina K, Carter SF, Nordberg AK. IC-03-03: COMPARISON OF MEASUREMENTS OF CEREBRAL BLOOD FLOW BY EARLY FRAMES OF 11C-DEUTERIUM-L-DEPRENYL (11C-DED) AND 11C-PIB PET TRACERS AT DIFFERENT STAGES OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P7-P7. DOI: 10.1016/J.Jalz.2014.04.032 |
0.446 |
|
| 2013 |
Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall AE, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB. Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology. 80: 1048-56. PMID 23390179 DOI: 10.1212/Wnl.0B013E3182872830 |
0.659 |
|
| 2013 |
Edison P, Carter SF, Rinne JO, Gelosa G, Herholz K, Nordberg A, Brooks DJ, Hinz R. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET. Neuroimage. 70: 423-33. PMID 23261639 DOI: 10.1016/J.Neuroimage.2012.12.014 |
0.727 |
|
| 2013 |
Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Forsberg A, Långström B, Scheinin N, Karrasch M, Någren K, Grimmer T, Miederer I, Edison P, et al. A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 40: 104-14. PMID 22961445 DOI: 10.1007/S00259-012-2237-2 |
0.788 |
|
| 2013 |
Chiotis K, Carter S, Nordberg A. P1-320: Comparison of PiB-PET data to florbetapir-PET data acquired from cohorts at different research sites Alzheimer's & Dementia. 9: P275-P275. DOI: 10.1016/J.Jalz.2013.05.546 |
0.701 |
|
| 2013 |
Chiotis K, Carter S, Nordberg A. Comparison of PiB-PET data to florbetapir-PET data acquired from different patient cohorts at different research sites Alzheimers & Dementia. 9: 13. DOI: 10.1016/J.Jalz.2013.05.007 |
0.717 |
|
| 2013 |
Schöll M, Carter S, Westman E, Almkvist O, Wall A, Graff C, Långström B, Nordberg A. O4-07-02: Longitudinal multi-tracer positron emission tomography studies of astrocytosis, fibrillar amlyloid deposition and cerebral glucose metabolism during development of early-onset familial Alzheimer's disease Alzheimer's & Dementia. 9: P695-P695. DOI: 10.1016/J.Jalz.2013.04.372 |
0.675 |
|
| 2012 |
Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 37-46. PMID 22213821 DOI: 10.2967/Jnumed.110.087031 |
0.763 |
|
| 2012 |
Carter SF, Caine D, Burns A, Herholz K, Lambon Ralph MA. Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease. International Journal of Geriatric Psychiatry. 27: 423-32. PMID 21618285 DOI: 10.1002/Gps.2738 |
0.632 |
|
| 2012 |
Lewis J, Anton-Rodriguez J, Carter SF, Herholz K, Asselin MC, Hinz R. Optimization of high resolution PET iterative reconstruction with resolution modeling for image derived input function Ieee Nuclear Science Symposium Conference Record. 3999-4004. DOI: 10.1109/NSSMIC.2012.6551916 |
0.473 |
|
| 2011 |
Ng Y, Nordberg A, Carter S, Schöll M, Kadir A. P4-358: Different hierarchical cytoarchitectonic sub-type vulnerability to Aβ-deposits and gray matter loss in AD and MCI patients: A comparison between a young and old cohort Alzheimer's & Dementia. 7: e37-e38. DOI: 10.1016/J.Jalz.2011.09.173 |
0.56 |
|
| 2011 |
Carter SF, Nordberg A, Schöll M, Almkvist O, Wall A, Engler H, Långström B. O1-07-05: Investigating astrocytosis with 11C-deuterium-L-Deprenyl in mild cognitive impairment and mild Alzheimer's disease: A multi tracer PET paradigm combining 11C-PIB and 18F-FDG Alzheimer's & Dementia. 7: S110-S110. DOI: 10.1016/J.Jalz.2011.05.276 |
0.733 |
|
| 2010 |
Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A. P4-089: Investigating Astrocytes With C11-deuterium Deprenyl in Mild Cognitive Impairment and Mild Alzheimer's - A Multi-tracer Positron Emission Tomography Paradigm Alzheimer's & Dementia. 6: e48-e49. DOI: 10.1016/J.Jalz.2010.08.149 |
0.722 |
|
| 2010 |
Carter SF, Burns A, Lambon Ralph MA, Herholz K. Longitudinal confirmation of a dissociation between tissue loss and functional impairment in MCI and late-onset Alzheimer's Alzheimer's & Dementia. 6: S300. DOI: 10.1016/J.Jalz.2010.05.981 |
0.585 |
|
| 2009 |
Carter S, Parker G, Ralph ML, Herholz K. Combining FDG-PET, structural MRI and probabilistic tractography in Alzheimer's disease Neuroimage. 47. DOI: 10.1016/S1053-8119(09)71032-8 |
0.649 |
|
| 2009 |
Nordberg A, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Almkvist O, Scheinin N, Grimmer T, Okello A, Van Laere K, Hinz R, Carter SF, Kalbe E, Herholz K. IC-S1-03: PET Amyloid imaging and cognition in patients with Alzheimer's disease, Mild Cognitive Impairment (MCI) and healthy controls: a European multicenter study Alzheimer's & Dementia. 5: P2-P2. DOI: 10.1016/J.Jalz.2009.05.006 |
0.759 |
|
| 2008 |
Carter SF. P1-334: Combining positron emission tomography and probabilistic tractography in Alzheimer's disease Alzheimer's & Dementia. 4: T316-T317. DOI: 10.1016/J.Jalz.2008.05.915 |
0.465 |
|
| 2007 |
Herholz K, Carter SF, Jones M. Positron emission tomography imaging in dementia. The British Journal of Radiology. 80: S160-7. PMID 18445746 DOI: 10.1259/Bjr/97295129 |
0.704 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2022 |
Low A, Prats-Sedano MA, Stefaniak JD, McKiernan EF, Carter SF, Douvani ME, Mak E, Su L, Stupart O, Muniz G, Ritchie K, Ritchie CW, Markus HS, O'Brien JT. CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 35135868 DOI: 10.1136/jnnp-2021-327462 |
0.282 |
|
| 2022 |
Low A, Prats-Sedano MA, McKiernan E, Carter SF, Stefaniak JD, Nannoni S, Su L, Dounavi ME, Muniz-Terrera G, Ritchie K, Lawlor B, Naci L, Malhotra P, Mackay C, Koychev I, et al. Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study. Alzheimer's Research & Therapy. 14: 154. PMID 36224605 DOI: 10.1186/s13195-022-01095-4 |
0.266 |
|
| 2020 |
Ehrenberg AJ, Khatun A, Coomans E, Betts MJ, Capraro F, Thijssen EH, Senkevich K, Bharucha T, Jafarpour M, Young PNE, Jagust W, Carter SF, Lashley T, Grinberg LT, Pereira JB, et al. Relevance of biomarkers across different neurodegenerative. Alzheimer's Research & Therapy. 12: 56. PMID 32404143 DOI: 10.1186/S13195-020-00601-W |
0.229 |
|
| 2020 |
Young PNE, Estarellas M, Coomans E, Srikrishna M, Beaumont H, Maass A, Venkataraman AV, Lissaman R, Jiménez D, Betts MJ, McGlinchey E, Berron D, O'Connor A, Fox NC, Pereira JB, ... ... Carter SF, et al. Imaging biomarkers in neurodegeneration: current and future practices. Alzheimer's Research & Therapy. 12: 49. PMID 32340618 DOI: 10.1186/S13195-020-00612-7 |
0.211 |
|
| 2020 |
Ehrenberg AJ, Khatun A, Coomans E, Betts MJ, Capraro F, Thijssen EH, Senkevich K, Bharucha T, Jafarpour M, Young PNE, Jagust W, Carter SF, Lashley T, Grinberg LT, Pereira JB, et al. Correction to: Relevance of biomarkers across different neurodegenerative diseases. Alzheimer's Research & Therapy. 12: 71. PMID 32517788 DOI: 10.1186/S13195-020-00637-Y |
0.163 |
|
| 2024 |
Lau WY, Ke GN, Yip TM, Wong RMM, Kamal KA, Lee SC, Carter S, Khairudin R, Grajfoner D. Socioeconomic impact and sufficiency of government financial support during COVID-19 pandemic: A retrospective study. Plos One. 19: e0302979. PMID 38781248 DOI: 10.1371/journal.pone.0302979 |
0.12 |
|
| 2024 |
Phuong J, Moles R, Mason D, White C, Center J, Carter S. Osteoporosis screening in Australian community pharmacies: A mixed methods study. Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals. PMID 38778716 DOI: 10.1002/hpja.876 |
0.12 |
|
| 2016 |
Casey JP, Brennan K, Scheidel N, McGettigan P, Lavin PT, Carter S, Ennis S, Dorkins H, Ghali N, Blacque O, Mc Gee MM, Murphy H, Lynch SA. Recessive NEK9 mutation causes a lethal skeletal dysplasia with evidence of cell cycle and ciliary defects. Human Molecular Genetics. PMID 26908619 DOI: 10.1093/Hmg/Ddw054 |
0.096 |
|
| 2016 |
Jensen VL, Carter S, Sanders AA, Li C, Kennedy J, Timbers TA, Cai J, Scheidel N, Kennedy BN, Morin RD, Leroux MR, Blacque OE. Whole-Organism Developmental Expression Profiling Identifies RAB-28 as a Novel Ciliary GTPase Associated with the BBSome and Intraflagellar Transport. Plos Genetics. 12: e1006469. PMID 27930654 DOI: 10.1371/Journal.Pgen.1006469 |
0.08 |
|
| 2004 |
Carter S. Brand: a company's most valuable asset. Medical Device Technology. 15: 11. PMID 15285479 |
0.078 |
|
| 2022 |
Ke GN, Grajfoner D, Carter S, DeLima N, Khairudin R, Lau WY, Kamal KA, Lee SC. Psychological Wellbeing and Employability of Retrenched Workforce During COVID-19: A Qualitative Study Exploring the Mitigations for Post Pandemic Recovery Phase. Frontiers in Public Health. 10: 907797. PMID 35875037 DOI: 10.3389/fpubh.2022.907797 |
0.076 |
|
| 2017 |
Gottlieb K, Le C, Wacher V, Sliman J, Cruz C, Porter T, Carter S. Selection of a cut-off for high- and low-methane producers using a spot-methane breath test: results from a large north American dataset of hydrogen, methane and carbon dioxide measurements in breath. Gastroenterology Report. PMID 28130375 DOI: 10.1093/gastro/gow048 |
0.066 |
|
| 2012 |
White L, Klinner C, Carter S. Consumer perspectives of the Australian Home Medicines Review Program: benefits and barriers. Research in Social & Administrative Pharmacy : Rsap. 8: 4-16. PMID 21493164 DOI: 10.1016/j.sapharm.2010.11.003 |
0.056 |
|
| 2024 |
Kassis A, Moles R, Carter S. Stakeholders' perspectives and experiences of the pharmacist's role in deprescribing in ambulatory care: A qualitative meta-synthesis. Research in Social & Administrative Pharmacy : Rsap. PMID 38685144 DOI: 10.1016/j.sapharm.2024.04.014 |
0.055 |
|
| 2006 |
Luo W, Zderic V, Carter S, Crum L, Vaezy S. Detection of bleeding in injured femoral arteries with contrast-enhanced sonography. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 25: 1169-77. PMID 16929018 DOI: 10.7863/Jum.2006.25.9.1169 |
0.055 |
|
| 2007 |
Lewis RBJ, Barker LN, Bryant EG, Carter SF, Spirit DM, Widdowson T, Wright JV. Demonstration of 2.488 Gbit/s transmission on the UK - Channel Islands No 7 submarine cable system Bt Technology Journal. 25: 44-50. DOI: 10.1007/s10550-007-0057-x |
0.051 |
|
| 2020 |
El-Den S, Schneider C, Mirzaei A, Carter S. How to measure a latent construct: Psychometric principles for the development and validation of measurement instruments. The International Journal of Pharmacy Practice. PMID 31944468 DOI: 10.1111/ijpp.12600 |
0.046 |
|
| 2022 |
Ke GN, Grajfoner D, Wong RMM, Carter S, Khairudin R, Lau WY, Kamal KA, Lee SC. Building the Positive Emotion-Resilience-Coping Efficacy Model for COVID-19 Pandemic. Frontiers in Psychology. 13: 764811. PMID 35369195 DOI: 10.3389/fpsyg.2022.764811 |
0.046 |
|
| 2024 |
Rezae F, Kelly A, Dey S, Moles R, Carter S. Healthcare professionals' perspectives and experiences of osteoporosis medication treatment: a qualitative systematic review. Archives of Osteoporosis. 19: 8. PMID 38191760 DOI: 10.1007/s11657-023-01359-y |
0.045 |
|
| 2023 |
Henderson SR, Horsley H, Frankel P, Khosravi M, Goble T, Carter S, Antonelou M, Evans RDR, Zhang X, Chu TY, Lin HH, Gordon S, Salama AD. Proteinase 3 promotes formation of multinucleated giant cells and granuloma-like structures in patients with granulomatosis with polyangiitis. Annals of the Rheumatic Diseases. PMID 36801813 DOI: 10.1136/ard-2021-221800 |
0.043 |
|
| 2020 |
Czarniak P, Krass I, Sunderland B, Sim TF, Carter S. Factors associated with the intensity of government remunerated and unremunerated service provision in community pharmacies. Research in Social & Administrative Pharmacy : Rsap. PMID 33423903 DOI: 10.1016/j.sapharm.2020.12.014 |
0.043 |
|
| 2024 |
Tran S, Smith L, Carter S. Understanding Patient Perspectives on the Use of Gamification and Incentives in mHealth Apps to Improve Medication Adherence: Qualitative Study. Jmir Mhealth and Uhealth. 12: e50851. PMID 38743461 DOI: 10.2196/50851 |
0.043 |
|
| 2003 |
Carter S. Innovation and patents: in vitro diagnostics. Medical Device Technology. 14: 24. PMID 12774574 |
0.041 |
|
| 1977 |
Carter S, Faulkner E. New phase-sensitive rectifier circuit Electronics Letters. 13: 439. DOI: 10.1049/EL:19770318 |
0.035 |
|
| 2022 |
Tran S, Smith L, El-Den S, Carter S. The Use of Gamification and Incentives in Mobile Health Apps to Improve Medication Adherence: Scoping Review. Jmir Mhealth and Uhealth. 10: e30671. PMID 35188475 DOI: 10.2196/30671 |
0.035 |
|
| 1989 |
France PW, Carter SF, Moore MW, Williams JR. Synthesis and Characterisation of Heavy Metal Fluoride Glasses and Fibres Mrs Proceedings. 172. DOI: 10.1557/PROC-172-135 |
0.033 |
|
| 2004 |
Caselli A, Hanane T, Jane B, Carter S, Khaodhiar L, Veves A. Topical methyl nicotinate-induced skin vasodilation in diabetic neuropathy. Journal of Diabetes and Its Complications. 17: 205-10. PMID 12810244 DOI: 10.1016/s1056-8727(02)00256-8 |
0.029 |
|
| 2005 |
Carter SF. Quality of service in BT's MPLS-VPN platform Bt Technology Journal. 23: 61-72. DOI: 10.1007/s10550-005-0007-4 |
0.027 |
|
| 2018 |
O'Brien JW, Grant S, Banks APW, Bruno R, Carter S, Choi PM, Covaci A, Crosbie ND, Gartner C, Hall W, Jiang G, Kaserzon S, Kirkbride KP, Lai FY, Mackie R, et al. A National Wastewater Monitoring Program for a better understanding of public health: A case study using the Australian Census. Environment International. PMID 30554870 DOI: 10.1016/J.Envint.2018.12.003 |
0.025 |
|
| 2004 |
Carter S. Patents versus settling for the soft option Medical Device Technology. 15: 19. PMID 15154334 |
0.025 |
|
| 2022 |
Pham L, Moles RJ, O'Reilly CL, Carter S, Raynes-Greenow C, Chen TF, Raduescu C, Randall S, Bloomfield J, Strowel C, Murphy A, Gardner D, El-Den S. Perinatal Women's Views of Pharmacist-Delivered Perinatal Depression Screening: A Qualitative Study. International Journal of Environmental Research and Public Health. 19. PMID 36498368 DOI: 10.3390/ijerph192316295 |
0.024 |
|
| 2004 |
Carter S. Patents and investors Medical Device Technology. 15: 11. PMID 15255529 |
0.022 |
|
| 2020 |
Carter S, Ng R, El-Den S, Schneider C. Low perceived service quality in community pharmacy is associated with poor medication adherence. Patient Education and Counseling. PMID 32788130 DOI: 10.1016/j.pec.2020.07.009 |
0.022 |
|
| 1983 |
Carter SF, France PW. Drawing induced absorption loss in multicomponent glass fibres Journal of Non-Crystalline Solids. 58: 47-55. DOI: 10.1016/0022-3093(83)90102-3 |
0.018 |
|
| 2018 |
Gottlieb K, Le C, Wacher V, Sliman J, Cruz C, Porter T, Carter S. Erratum: Selection of a cut-off for high- and low-methane producers using a spot-methane breath test: results from a large north American dataset of hydrogen, methane and carbon dioxide measurements in breath. Gastroenterology Report. 6: 242. PMID 30151210 DOI: 10.1093/gastro/gox015 |
0.017 |
|
| 2004 |
Carter S. A level playing field for intellectual property enforcement. Medical Device Technology. 15: 11. PMID 15303555 |
0.015 |
|
| 2015 |
Kritikos VS, Saini B, Carter S, Moles RJ, Krass I. Factors influencing pharmacy students' attitudes towards pharmacy practice research and strategies for promoting research interest in pharmacy practice. Pharmacy Practice. 13: 587. PMID 26445620 DOI: 10.18549/PharmPract.2015.03.587 |
0.015 |
|
| 2009 |
Carmi S, Carter S, Sun J, Ben-Avraham D. Asymptotic behavior of the Kleinberg model. Physical Review Letters. 102: 238702. PMID 19658979 DOI: 10.1103/Physrevlett.102.238702 |
0.013 |
|
| 2004 |
Schein PS, Scheffler B, Carter S. The role of the FDA in the national cancer program: friend or foe? The Oncologist. 8: 501-6. PMID 14657526 DOI: 10.1634/theoncologist.8-6-501 |
0.011 |
|
| 1985 |
Beales KJ, Carter SF, France PW, Partington S. Multicomponent glass optical fibres with a lowered water content and reduced loss Journal of Non-Crystalline Solids. 70: 253-262. DOI: 10.1016/0022-3093(85)90324-2 |
0.011 |
|
| 2023 |
Strowel C, Raynes-Greenow C, Pham L, Carter S, Birkness K, Moles RJ, O'Reilly CL, Chen TF, Raduescu C, Murphy A, Gardner D, El-Den S. Perinatal depression screening in community pharmacy: Exploring pharmacists' roles, training and resource needs using content analysis. International Journal of Clinical Pharmacy. 45: 1212-1222. PMID 37792255 DOI: 10.1007/s11096-023-01647-0 |
0.01 |
|
| 2019 |
Carter S. Orthomolecular Medicine. Integrative Medicine (Encinitas, Calif.). 18: 74. PMID 32549818 |
0.01 |
|
| 2005 |
Carter S. Attack can be the best form of defence. Medical Device Technology. 15: 37. PMID 16225273 |
0.01 |
|
| 2004 |
Carter S. Do you own your intellectual property? Medical Device Technology. 14: 8. PMID 14603711 |
0.01 |
|
| 2003 |
Carter S. Community registered design. Medical Device Technology. 14: 8. PMID 12789691 |
0.01 |
|
| 1984 |
France Pw, Carter SF, Williams JR. NH+4Absorption in Fluoride Glass Infrared Fibers Journal of the American Ceramic Society. 67: c243-c244. DOI: 10.1111/J.1151-2916.1984.TB19497.X |
0.01 |
|
| 1977 |
Carter S, Faulkner E. Accurate broadband square-to-triangle convertor Electronics Letters. 13: 381. DOI: 10.1049/EL:19770276 |
0.01 |
|
| Hide low-probability matches. |